Delivery Order SPE2DR25D1017-SPE2DR26F9BAK
- Not listed
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The order is for 1,000 units of the medication Lisinopril-HCTZ 20-25 mg tablets, with a potential value of $1,459.16. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of 1,000 tablets of Lisinopril-HCTZ 10-12.5 mg, a common antihypertensive medication used in military and federal healthcare systems. This firm fixed-price delivery order, valued at $1,199.34, represents a non-competitive set-aside award and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 24, 2025. The...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,566,088 units of Lisinopril-HCTZ 20-25 mg tablets, with a ceiling value of $1,027.91 and a period of performance through October 15, 2024. AmerisourceBergen has been awarded multiple federal contracts and Indefinite Delivery Contracts (IDCs) by DLA and other agencies, including a $999,999,999 IDC with DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 units of the medication Lisinopril-HCTZ 20-25 mg tablets, with a ceiling value of $1,150.62. The contract is for a fixed price and has an ultimate completion date of June 24, 2025. The contract is not set aside for any specific small business designation. AmerisourceBergen Drug...
- Amerisourcebergen Drug Corp, through its Corporate Office division, was awarded a firm fixed price delivery order contract (SPE2DX15D1205|SPE2DX24F51J0) by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, to supply 4563906279 - Lisinopril-HCTZ 10-12.5 mg tablets in 1000 count bottles. The contract has a ceiling value of $2,677.06 and a period of performance through March 11, 2024. This delivery order is part of a larger $999,999,999.00...
- The Defense Logistics Agency awarded a $1,248.47 delivery order to AmerisourceBergen Drug Corp for Lisinopril tablets, with an ultimate completion date of October 29, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at $999,999,999.00 and extends through December 2026. The delivery order will be performed at AmerisourceBergen's corporate...
- This is a $1,290.84 delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of 1,000 units of the pharmaceutical product Lisinopril-HCTZ 20-12.5 mg tablets. The contract is a firm fixed price delivery order with a performance period through January 8, 2024. Amerisourcebergen Drug Corp is the prime...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for $1,903.83. The order is for the pharmaceutical product Lisinopril-HCTZ 20-25 mg tablets, a quantity of 1,000. The delivery order is a firm-fixed-price contract type with a completion date of September 5, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor and has been awarded multiple indefinite delivery contracts by the DLA Troop Support Medical and the...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $15,440 to Amerisourcebergen Drug Corporation for the supply of 90 tablets of 20-12.5 mg Lisinopril-HCTZ. Place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania over the period of September 21-22, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for the hypertension medication furthers the Agency's...
- The Defense Logistics Agency awarded a delivery order valued at $4,131.97 to AmerisourceBergen Drug Corp for 1,000 tablets of Lisinopril 40 mg, with an ultimate completion date of September 9, 2025. This non-set-aside contract employs firm fixed price terms and represents a direct fulfillment order under AmerisourceBergen's existing contract vehicle with DLA. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9BAKDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on December 9, 2025, for the supply of Lisinopril-HCTZ 20-25 mg tablets (500 count) with a ceiling value of $6,953.93. The contract employs firm fixed pricing and is scheduled for completion by December 10, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle valued through December 2026 that provides comprehensive global pharmaceutical support to military healthcare programs worldwide. The award represents a competitively awarded, non-set-aside delivery order supporting the Defense Logistics Agency's medical supply chain operations. This transaction exemplifies AmerisourceBergen's established role as a critical federal vendor for pharmaceutical procurement, supplying both generic and brand-name medications across multiple therapeutic domains to the Department of Defense, Defense Health Agency, and other government healthcare systems. The delivery order maintains the firm fixed price structure consistent with the company's portfolio of federal medical supply contracts, which range from small-value transactions to substantial orders exceeding $45,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 12/8/25 |